[{"id":"84ba164f-a8bd-4f3b-9415-aab2f11fe8cf","acronym":"","url":"https://clinicaltrials.gov/study/NCT06072586","created_at":"2023-10-10T15:12:11.838Z","updated_at":"2024-07-02T16:35:27.961Z","phase":"Phase 1","brief_title":"Study of BDTX-1535 in Recurrent High-Grade Glioma (HGG) Participants With EGFR Alterations or Fusions","source_id_and_acronym":"NCT06072586","lead_sponsor":"St. Joseph's Hospital and Medical Center, Phoenix","biomarkers":" EGFR","pipe":"","alterations":" ","tags":["EGFR"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e silevertinib (BDTX-1535)"],"overall_status":"Recruiting","enrollment":" Enrollment 22","initiation":"Initiation: 10/18/2023","start_date":" 10/18/2023","primary_txt":" Primary completion: 05/01/2025","primary_completion_date":" 05/01/2025","study_txt":" Completion: 10/31/2025","study_completion_date":" 10/31/2025","last_update_posted":"2023-11-28"}]